Rigel Pharmaceuticals (RIGL) Operating Margin Growth (5y) (2015 - 2026)
Rigel Pharmaceuticals (RIGL) Operating Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,133.00 |
| Dec 31, 2025 | 13,524.00 |
| Sep 30, 2025 | 11,586.00 |
| Jun 30, 2025 | 16,865.00 |
| Mar 31, 2025 | -1,376.00 |
| Dec 31, 2024 | 14,149.00 |
| Sep 30, 2024 | 8,313.00 |
| Jun 30, 2024 | 20,626.00 |
| Mar 31, 2024 | 12,199.00 |
| Dec 31, 2023 | -120.00 |
| Sep 30, 2023 | 48,505.00 |
| Jun 30, 2023 | 144,157.00 |
| Dec 31, 2022 | -58,058.00 |
| Sep 30, 2022 | 190,177.00 |
| Mar 31, 2022 | 29,514.00 |
| Dec 31, 2021 | 42,129.00 |
| Sep 30, 2021 | 51,292.00 |
| Jun 30, 2021 | 10,913.00 |
| Mar 31, 2021 | 40,085.00 |
| Dec 31, 2020 | 4,727.00 |